Effect of Sleep Extension on Ceramides in People with Overweight and Obesity
Part of paid clinical trials in Salt Lake City, Utah.
- Sponsor
- University of Utah
- Study ID
- NCT06180837
- Status
- Recruiting
Conditions
- Eating Habit
- Insufficient Sleep Syndrome
- Insulin Sensitivity
- Lifestyle Factors
- Overweight and Obesity
- Sleep
- Sleep Deprivation
- Sleep Hygiene
- Type 2 Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Accepted
Interventions
- Sleep Extension Intervention — BEHAVIORALSleep extension-based intervention focused on increasing time spent in bed by 2 hours per night by directly scheduling assigned bed and waketimes based on participant's individual schedules. Participants will receive weekly sleep tips and counseling on improving their sleep duration.
Study Details
The overall goal is to determine how a sleep extension intervention (increasing time in bed) in individuals who maintain less than 6.5 hours sleep per night affects their plasma ceramides and insulin sensitivity. Participants will undergo a randomized controlled trial, with sleep extension (intervention) and healthy lifestyle (control) groups. The sleep extension is designed to increase participant's time in bed by 2 hours per night. Alternatively, the control group will receive basic health information (e.g., physical activity, goal setting, and nutrition when eating out).
Key Dates
- Start date
- Feb 12, 2024
- Status verified
- Dec 2024
- Primary completion
- Jan 31, 2028
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- No Intervention: Control GroupProvided with general health information on diet and physical activity.
- Experimental: Intervention GroupSleep extension-based intervention focused on increasing time in bed by 2 hours per night.
Primary Outcome Measure
Total Plasma Ceramides [ Time Frame: Immediately after the intervention ]
Central Contacts
- Christopher M Depner, PhD801-581-2275
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| College of Health Research Complex--University of Utah | Salt Lake City | Utah | 84112 |
Find similar trials in Salt Lake City, UT
By condition
By specialty
Related Studies
- Circadian Intervention to Improve Cardiometabolic HealthRecruiting · University of Utah · Salt Lake City, Utah
- The Acute T-Rex (Timing of Resistance Exercise) StudyRecruiting · University of Utah · Salt Lake City, Utah
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)PHASE3 · Recruiting · Eli Lilly and Company · Tucson, Arizona
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)PHASE2 · Recruiting · Sparrow Pharmaceuticals · Chandler, Arizona